Berapa harga MultiCell Technologies, Inc. (MCET)

Harga MultiCell Technologies, Inc. (MCET) adalah $0.00001

Apa kapitalisasi pasar MultiCell Technologies, Inc. (MCET)

Kapitalisasi pasar MultiCell Technologies, Inc. (MCET) adalah $50.01K

MultiCell Technologies, Inc. (MCET) Pemecahan Saham

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

Tahun	Pemecahan	Kelipatan	Kelipatan Kumulatif
2005-05-20	1:5	x0.2	x0.0212
1992-12-01	1:10	x0.1	x0.106
1992-11-23	53:50	x1.06	x1.06

Tahun

Pemecahan

Kelipatan

Kelipatan Kumulatif

2005-05-20

1:5

x0.2

x0.0212

1992-12-01

1:10

x0.1

x0.106

1992-11-23

53:50

x1.06

Perusahaan	Jumlah pemecahan saham	Kelipatan Kumulatif	Negara
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
CSL Limited CSL.AX	1	x3	AU

Perusahaan

Jumlah pemecahan saham

Kelipatan Kumulatif

Negara